Milan, Italy

Costantino Palmieri


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1994-1997

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Costantino Palmieri: Innovator in Neuronal Treatment

Introduction

Costantino Palmieri is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of neuronal degenerative processes. With a total of 5 patents to his name, Palmieri continues to push the boundaries of innovation in his field.

Latest Patents

Among his latest patents, Palmieri has developed N-substituted trifluoromethylphenyltetrahydropyridines, which are crucial for treating neuronal degenerative processes. One of his methods involves administering a compound known as 1-[4-(3-trifluoromethylphenyl)-1, 2, 3, 6-tetrahydropyrid-1-yl]-2-)6, 7-dimethoxynaphth-2-yl)ethane or its pharmaceutically acceptable salts to mammals suffering from such conditions. Additionally, he has created new N-substituted 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridines that are useful in treating intestinal motility disorders.

Career Highlights

Palmieri's career is marked by his dedication to research and development in the pharmaceutical industry. He is currently associated with Sanofi, a leading global healthcare company. His work has not only advanced scientific understanding but has also paved the way for new therapeutic options for patients.

Collaborations

Throughout his career, Palmieri has collaborated with esteemed colleagues, including Umberto Guzzi and Tiziano Croci. These partnerships have enhanced his research efforts and contributed to the successful development of his innovative treatments.

Conclusion

Costantino Palmieri stands out as a prominent inventor in the field of medicinal chemistry. His innovative patents and collaborations reflect his commitment to improving healthcare solutions. His work continues to inspire advancements in the treatment of neuronal and intestinal disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…